Close

BofA/Merrill Lynch Downgrades Aegerion Pharmaceuticals (AEGR) to Underperform

October 31, 2014 8:26 AM EDT Send to a Friend
BofA/Merrill Lynch downgraded Aegerion Pharmaceuticals (NASDAQ: AEGR) from Buy to ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login